We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Pertuzumab/trastuzumab

Australian Public Assessment Report

AusPAR

AusPAR: Pertuzumab/trastuzumab [PDF, 340.42 KB]

AusPAR: Pertuzumab/trastuzumab [Word, 128.22 KB]

Attachment: Product information for Pertuzumab/trastuzumab [PDF, 471.04 KB]

Attachment: Product information for Pertuzumab/trastuzumab [Word, 413.58 KB]

Device/Product Name

Phesgo SC

Active ingredients

Pertuzumab/trastuzumab

AusPAR Date

20 September 2021

Published

11 October 2021

Submission Number

PM-2020-01326-1-4

Submission Type

New combination of active ingredients

Decision

Approved